XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Beginning balance at Dec. 31, 2022 $ 110,903 $ 43 $ 262,496 $ (151,605) $ (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Stock-based compensation expense 1,833   1,833    
Unrealized gain (loss) on marketable securities 31       31
Net loss (6,526)     (6,526)  
Ending balance at Mar. 31, 2023 106,241 $ 43 264,329 (158,131)  
Ending balance, shares at Mar. 31, 2023   43,269,200      
Beginning balance at Dec. 31, 2022 110,903 $ 43 262,496 (151,605) (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Unrealized gain (loss) on marketable securities 43        
Net loss (14,892)        
Ending balance at Jun. 30, 2023 99,930 $ 43 266,372 (166,497) 12
Ending balance, shares at Jun. 30, 2023   43,269,200      
Beginning balance at Mar. 31, 2023 106,241 $ 43 264,329 (158,131)  
Beginning balance, shares at Mar. 31, 2023   43,269,200      
Stock-based compensation expense 2,043   2,043    
Unrealized gain (loss) on marketable securities 12       12
Net loss (8,366)     (8,366)  
Ending balance at Jun. 30, 2023 99,930 $ 43 266,372 (166,497) 12
Ending balance, shares at Jun. 30, 2023   43,269,200      
Beginning balance at Dec. 31, 2023 81,720 $ 43 270,150 (188,554) 81
Beginning balance, shares at Dec. 31, 2023   43,909,069      
Issuance of common stock, net 161,756 $ 20 161,736    
Issuance of common stock, net, shares   19,736,842      
Vesting of restricted stock units   $ 1 (1)    
Vesting of restricted stock units, shares   153,750      
Exercise of stock options, shares   356      
Stock-based compensation expense 2,128   2,128    
Unrealized gain (loss) on marketable securities (106)       (106)
Net loss (14,654)     (14,654)  
Ending balance at Mar. 31, 2024 230,844 $ 64 434,013 (203,208) (25)
Ending balance, shares at Mar. 31, 2024   63,800,017      
Beginning balance at Dec. 31, 2023 $ 81,720 $ 43 270,150 (188,554) 81
Beginning balance, shares at Dec. 31, 2023   43,909,069      
Exercise of stock options, shares 2,856        
Unrealized gain (loss) on marketable securities $ (231)        
Net loss (36,281)        
Ending balance at Jun. 30, 2024 211,404 $ 64 436,325 (224,835) (150)
Ending balance, shares at Jun. 30, 2024   63,802,517      
Beginning balance at Mar. 31, 2024 230,844 $ 64 434,013 (203,208) (25)
Beginning balance, shares at Mar. 31, 2024   63,800,017      
Exercise of stock options 11   11    
Exercise of stock options, shares   2,500      
Stock-based compensation expense 2,301   2,301    
Unrealized gain (loss) on marketable securities (125)       (125)
Net loss (21,627)     (21,627)  
Ending balance at Jun. 30, 2024 $ 211,404 $ 64 $ 436,325 $ (224,835) $ (150)
Ending balance, shares at Jun. 30, 2024   63,802,517